News
The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...
'Master control switch' protein that heightens neurodegenerative disease offers new treatment target
UT Southwestern Medical Center scientists have identified a protein that appears to act as a master control switch for ...
Researchers at the University of Oklahoma are advancing the fight against inherited retinal diseases (IRDs) with new genetic ...
Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.
College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, P. R. China ...
Ocugen's drug to treat retina diseases received a rare pediatric disease designation from U.S. regulators. The biotechnology said Tuesday that the Food and Drug Administration granted the designation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results